Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 5/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.40 |
| ▸ | ADH1C | P00326 | 1/20 | 0.40 |
| ▸ | ADH1A | P07327 | 1/20 | 0.40 |
| ▸ | ADH4 | P08319 | 1/20 | 0.40 |
| ▸ | ADH7 | P40394 | 1/20 | 0.40 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3316130 | 1.00 | OPRM1 (0.46) | OPRM1FAAHCNR1CNR2SPHK1 | |
| SCHEMBL28216704 | 1.00 | OPRM1 (0.46) | OPRM1FAAHCNR1CNR2SPHK1 | |
| SCHEMBL11579490 | 1.00 | OPRM1 (0.46) | OPRM1FAAHCNR1CNR2SPHK1 | |
| SCHEMBL3317296 | 1.00 | OPRM1 (0.46) | OPRM1FAAHCNR1CNR2SPHK1 | |
| SCHEMBL29518544 | 1.00 | OPRM1 (0.46) | OPRM1FAAHCNR1CNR2SPHK1 | |
| SCHEMBL13555001 | 1.00 | OPRM1 (0.46) | OPRM1FAAHCNR1CNR2SPHK1 | |
| SCHEMBL12424296 | 1.00 | OPRM1 (0.46) | OPRM1FAAHCNR1CNR2SPHK1 | |
| SCHEMBL1142792 | 1.00 | OPRM1 (0.46) | OPRM1FAAHCNR1CNR2SPHK1 | |
| SCHEMBL22817316 | 1.00 | OPRM1 (0.46) | OPRM1FAAHCNR1CNR2SPHK1 | |
| SCHEMBL10447343 | 0.97 | OPRM1 (0.44) | OPRM1FAAHCNR1CNR2SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1150211-C | Siloxanes hydrogel polymers | �Ʒ� | 2004-05-19 | — | — | CN | claimed |
| CN-1218816-A | Siloxanes hydrogel polymers | JOHNSON & JOHNSON VISION PROD (US) | 1999-06-09 | — | — | CN | claimed |
| US-11001671-B2 | Diamine-diacid salt, copolymer and method for manufacturing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2021-05-11 | — | — | US | disclosed |
| US-20190144605-A1 | DIAMINE COMPOUND, DIAMINE-DIACID SALT, COPOLYMER AND METHOD FOR MANUFACTURING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2019-05-16 | — | — | US | disclosed |
| CN-105802758-B | Cleaning Agent for PCB agent after fire | 江苏筑磊电子科技有限公司 | 2019-04-05 | — | — | CN | disclosed |
| EP-2132167-B1 | METHOD FOR THE PRODUCTION OF beta-KETONITRILES | BASF SE (DE) | 2013-12-25 | — | — | EP | disclosed |
| US-8501748-B2 | Method for the production of β-ketonitriles | BASF SE (DE) | 2013-08-06 | — | — | US | disclosed |
| US-20130005970-A1 | Method for the production of beta-ketonitriles | BASF SE (DE) | 2013-01-03 | — | — | US | disclosed |
| US-8309751-B2 | Method for the production of β-ketonitriles | BASF SE (DE) | 2012-11-13 | — | — | US | disclosed |
| US-20100105903-A1 | Method for the production of beta-ketonitriles | BASF SE (DE) | 2010-04-29 | — | — | US | disclosed |
| EP-2132167-A1 | METHOD FOR THE PRODUCTION OF -KETONITRILES | BASF SE (DE) | 2009-12-16 | — | — | EP | disclosed |
| WO-2009064975-A1 | QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS | ENANTA PHARMACEUTICALS, INC. (US) | 2009-05-22 | — | — | WO | disclosed |
| WO-2008107397-A1 | METHOD FOR THE PRODUCTION OF β-KETONITRILES | BASF SE (DE) | 2008-09-12 | — | — | WO | disclosed |
| CN-1150211-C | Siloxanes hydrogel polymers | �Ʒ� | 2004-05-19 | — | — | CN | disclosed |
| CN-1218816-A | Siloxanes hydrogel polymers | JOHNSON & JOHNSON VISION PROD (US) | 1999-06-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130005970-A1 | Method for the production of beta-ketonitriles | AKR1C3, AKR1C4, AKR1C1 | OPRM1 3316/4885FAAH 470/4885CNR1 209/4885 |
| US-20190144605-A1 | DIAMINE COMPOUND, DIAMINE-DIACID SALT, COPOLYMER AND METHOD FOR MANUFACTURING THE SAME | DDC, SRM, ACMSD | OPRM1 2055/4885FAAH 3022/4885CNR1 2888/4885 |
| US-20100105903-A1 | Method for the production of beta-ketonitriles | AKR1C3, AKR1C4, AKR1C1 | OPRM1 3316/4885FAAH 470/4885CNR1 209/4885 |
| US-11001671-B2 | Diamine-diacid salt, copolymer and method for manufacturing the same | DDC, CA12, ACMSD | OPRM1 2379/4885FAAH 3626/4885CNR1 3066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.